Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages.
Autor: | Feng G; Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.; Institute of General Practice, Xi'an Medical University, 710021, Xi'an, China., Zhang X; Department of Gastroenterology, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing, 400038, China.; Institute of Digestive Diseases of PLA, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), 400038, Chongqing, China.; Center for Metabolic Associated Fatty Liver Disease and Cholestatic Liver Diseases Center, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), 400038, Chongqing, China., Zhang L; Department of Gastroenterology, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing, 400038, China.; Institute of Digestive Diseases of PLA, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), 400038, Chongqing, China.; Center for Metabolic Associated Fatty Liver Disease and Cholestatic Liver Diseases Center, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), 400038, Chongqing, China., Liu WY; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China., Geng S; Artificial Intelligence Unit, Department of Medical Equipment Management, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China., Yuan HY; MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, China., Sha JC; Interventional Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China., Wang XD; Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, Zhejiang, 325000, China., Sun DQ; Department of Nephrology, The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, 214001, Jiangsu, China., Targher G; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy., Byrne CD; Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton, University of Southampton, Southampton General Hospital, Southampton, UK., Zheng TL; Artificial Intelligence Unit, Department of Medical Equipment Management, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China.; School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, 221116, China., Ye F; Department of Infectious Disease, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China., Zheng MH; MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, 325000, Wenzhou, China.; Key Laboratory of Diagnosis and Treatment for The Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, Zhejiang, 325000, China., Chai J; Department of Gastroenterology, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), Chongqing, 400038, China.; Institute of Digestive Diseases of PLA, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), 400038, Chongqing, China.; Center for Metabolic Associated Fatty Liver Disease and Cholestatic Liver Diseases Center, The First Affiliated Hospital (Southwest Hospital), Third Military Medical University (Army Medical University), 400038, Chongqing, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2023 Jun; Vol. 43 (6), pp. 1234-1246. Date of Electronic Publication: 2023 Mar 27. |
DOI: | 10.1111/liv.15565 |
Abstrakt: | Background & Aims: There is an unmet clinical need for non-invasive tests to diagnose non-alcoholic fatty liver disease (NAFLD) and individual fibrosis stages. We aimed to test whether urine protein panels could be used to identify NAFLD, NAFLD with fibrosis (stage F ≥ 1) and NAFLD with significant fibrosis (stage F ≥ 2). Methods: We collected urine samples from 100 patients with biopsy-confirmed NAFLD and 40 healthy volunteers, and proteomics and bioinformatics analyses were performed in this derivation cohort. Diagnostic models were developed for detecting NAFLD (UP Results: The UP Conclusions: Our newly developed models constructed from urine protein biomarkers have good accuracy for non-invasively diagnosing liver fibrosis in NAFLD. (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |